New Treatments For Patients With Colorectal And Liver Cancer – Part 1 of 3
New Treatments For Patients With Colorectal And Liver Cancer. For advanced colon cancer patients who have developed liver tumors, designated “radioactive beads” implanted near these tumors may carry on survival nearly a year longer than among patients on chemotherapy alone, a small new study finds. The same study, however, found that a drug commonly infatuated in the months before the procedure does not increase this survival benefit. The research, from Beaumont Hospitals in Michigan, helps advance the understanding of how various treatment combinations for colorectal cancer – the third most shared cancer in American men and women – affect how well each individual treatment works.
And “I definitely think there’s a lot of room for studying the associations between different types of treatments,” said workroom author Dr Dmitry Goldin, a radiology resident at Beaumont. “There are constantly new treatments, but they come out so fast that we don’t always know the consequences or complications of the associations. We call to study the sequence, or order, of treatments”.
The study is scheduled to be presented Saturday at the International Symposium on Endovascular Therapy in Miami Beach, Fla. Research presented at scientific conferences has not been peer-reviewed or published and should be considered preliminary. Goldin and his colleagues reviewed medical records from 39 patients with advanced colon cancer who underwent a scheme known as yttrium-90 microsphere radioembolization.